Sign In
Buy DGX
$233.01
-1.29 (-0.551%)
At Close: Jul 31, 2026
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?
11:11am, Friday, 31'st Jul 2026
Quest Diagnostics' earnings beat, raised 2026 outlook and broad testing demand support momentum, but valuation, debt and margin pressure temper the buy case.
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
01:35pm, Thursday, 30'th Jul 2026
DGX's broad testing demand, payer access, advanced diagnostics and partnerships support 2026 growth as AI and automation target costs.
Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics
07:30am, Thursday, 30'th Jul 2026
Largest nationally representative study finds 12% of patients positive for bacterial vaginosis are infected with at least one STI, such as chlamydia or gonorrhea SECAUCUS, N.J., July 30, 2026 /PRNewsw
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:41am, Tuesday, 28'th Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Quest Diagnostics Stock Climbed This Past Week
10:02pm, Sunday, 26'th Jul 2026
Partnerships with other healthcare leaders are accelerating Quest's growth. AI is making the health insights provider more profitable.
Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice
01:01pm, Friday, 24'th Jul 2026
Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
10:50am, Friday, 24'th Jul 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
10:16am, Friday, 24'th Jul 2026
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 Results
05:59am, Friday, 24'th Jul 2026
Quest Diagnostics earns a reiterated buy rating after Q2 earnings beat, upgraded FY guidance, and continued market momentum. DGX benefits from strong macro demand for specialized diagnostic testing, p
Quest Diagnostics Q2 Earnings Call Highlights
03:08pm, Thursday, 23'rd Jul 2026
Quest Diagnostics NYSE: DGX reported double-digit revenue growth and raised its full-year 2026 outlook after what executives described as strong demand across its physician, hospital and consumer chan
Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call Transcript
02:30pm, Thursday, 23'rd Jul 2026
Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call Transcript
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning
01:47pm, Thursday, 23'rd Jul 2026
Quest Diagnostics Incorporated (NYSE:DGX) stock surged Thursday after the diagnostic testing company reported second-quarter results that topped Wall Street expectations and raised its full-year 2026
DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised
10:31am, Thursday, 23'rd Jul 2026
Quest Diagnostics shares rise as second-quarter earnings and revenues beat estimates, testing demand surges and the company raises its 2026 outlook.
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
09:01am, Thursday, 23'rd Jul 2026
Quest Diagnostics (DGX) came out with quarterly earnings of $3.12 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $2.62 per share a year ago.
Quest Diagnostics raises annual forecast on testing demand
07:41am, Thursday, 23'rd Jul 2026
Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped the company beat second-quarter estimates.
